About this trial

A prospective, single arm, non-randomized, pivotal clinical validation study to evaluate the ability of the Kintsugi Voice Device (the Device) to aid clinical assessment for depression by comparing its output with a diagnosis made by a clinician using the Structured Clinical Interview for DSM-5 (SCID-5-RV) for up to 1000 English speaking adult patients ages 22 and older living in the United States. Recruitment will occur for 1 year and participation will be for up to 2 weeks

Eligibility criteria

Qualifiers

None

Disqualifiers

None

Trial design

Treatments tested in this trial

  • Kintsugi Voice Device

Treatment groups

No treatment groups listed

Locations

1
Kintsugi (Decentralized, Virtual Study)94707, BerkeleyCalifornia, United States

Sponsors and collaborators

Kintsugi Mindful Wellness, Inc.

Lead sponsor

Kolby Walker, DO

Collaborator

Sonar Strategies

Collaborator

Brittany Kimble

Collaborator